Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Hurlburt Elizabeth. Director active across 1 company, notably CorMedix Inc.. Aggregated, 11 disclosures have been logged. History available since 14 November 2024. The latest transaction was disclosed on 29 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
Elizabeth Hurlburt is Chief Operating Officer at CorMedix Inc. The 10 filings recorded, all for CorMedix Inc., cover the period from 2024-11-18 to 2026-02-06 in the sampled filings, with transactions shown as Attribution and amounts listed including EUR 112747.1801666348, EUR 106944.5493817569, and EUR 62917.66266433011.